Joshi Alumkal

Associate Professor

  • 2910 Citations
  • 26 h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Joshi Alumkal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • PACIFIC NORTHWEST PROSTATE CANCER SPORE

    Garzotto, M., Alumkal, J., Higano, C., Hood, L., Lange, P., Plymate, S., Mostaghel, E., Vessella, R. L., Etzioni, R., Gleave, M., Yu, E. Y. -., Stanford, J., Nelson, P. & Etzioni, R.

    National Institutes of Health

    9/19/028/31/18

    Project: Research project

  • Research Output

    Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4

    Coleman, D. J., Sampson, D. A., Sehrawat, A., Kumaraswamy, A., Sun, D., Wang, Y., Schwartzman, J., Urrutia, J., Lee, A. R., Coleman, I. M., Nelson, P. S., Dong, X., Morrissey, C., Corey, E., Xia, Z., Yates, J. A. & Alumkal, J. J., Jun 2020, In : Neoplasia (United States). 22, 6, p. 253-262 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer

    Chen, W. S., Feng, E. L., Aggarwal, R., Foye, A., Beer, T. M., Alumkal, J., Gleave, M., Chi, K. N., Reiter, R. E., Rettig, M. B., Evans, C. P., Small, E. J., Sharifi, N. & Zhao, S. G., Jun 1 2020, In : Prostate Cancer and Prostatic Diseases. 23, 2, p. 316-323 8 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer

    Coleman, D. J., Gao, L., King, C. J., Schwartzman, J., Urrutia, J., Sehrawat, A., Tayou, J., Balter, A., Burchard, J., Chiotti, K. E., Derrick, D. S., Sun, D., Xia, Z., Heiser, L. M. & Alumkal, J. J., Jul 11 2019, In : Oncogene. 38, 28, p. 5658-5669 12 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

    Ferrari, A. C., Alumkal, J. J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. M., Apr 15 2019, In : Clinical Cancer Research. 25, 8, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer

    Ferrari, A. C., Alumkal, J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. T., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 52-63 12 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations